Apply for a share of up to £25 million for ambitious or disruptive R&D innovations
Secure the funding you need to progress your projects towards commercialisation.
We’re looking for game changing, disruptive, and innovative companies to partner with for the Innovate UK Smart Grants: April 2019.
Opportunity to apply for a share of up to £25 million to deliver ambitious or disruptive R&D innovations with significant potential for impact on the UK economy.
Why partner with the Medicines Discovery Catapult?
- Our experienced commercial and scientific teams have connections across industry, academia, finance, government, and research networks – we can help take your projects further towards commercial viability.
- We have specialist grant writing expertise to work with you in crafting top quality grant applications.
- Our team have a wealth of industrial and academic expertise applied to drug discovery, complex cell models, assay development, biomarker identification, and validation.
- You’ll have supported access, with specialist expertise, to cutting edge technologies including multi-omics capabilities, mass spec quantitation, mass spec imaging, and organ-on-a-chip capabilities.
- Our team are experts in translating analytical methodologies that are sensitive, specific, and robust for clinical utility.
- Our Informatics team have deep expertise in natural language processing, data analysis, machine learning, cheminformatics, and bioinformatics.
- We can providing access to information thats not readily available around target validation, drug target interaction, and downstream consequences of engagement.
- We can help unlock access to appropriately consented patient Samples & Data.
- We’ll give you access to a network of clinical, academic, and industry experts via Virtual R&D.